株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の癌/腫瘍プロファイリング市場:2019年~2025年の予測

Global Cancer/Tumor Profiling Market 2019-2025

発行 Orion Market Research Pvt Ltd 商品コード 918156
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.11円で換算しております。
世界の癌/腫瘍プロファイリング市場:2019年~2025年の予測 Global Cancer/Tumor Profiling Market 2019-2025
出版日: 2019年10月10日 ページ情報: 英文
概要

当レポートは世界の癌/腫瘍プロファイリング市場について調査しており、市場機会、成長および阻害要因、技術・癌のタイプ・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査方法・ツール
  • 市場分析
    • セグメント別
    • 地域別
    • 利害関係者別

第2章 市場の概要および洞察

  • レポートの範囲
  • アナリストの洞察およびの市場動向
    • 主な調査結果
    • 提言
    • 結論
  • 規則・規制

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略分析
  • 主要企業分析
    • F. Hoffmann-La Roche Ltd.
    • Genomic Health, Inc.
    • Sysmex Corp.
    • QIAGEN N.V.
    • Illumina, Inc.

第4章 市場の決定要因

  • 成長要因
  • 阻害要因
  • 市場機会

第5章 市場セグメンテーション

  • 技術別
    • イムノアッセイ
    • In situ ハイブリダイゼーション
    • シーケンス技術
    • 質量分析
    • その他(マイクロアレイ)
  • 癌のタイプ別
    • 肺癌
    • 乳癌
    • 前立腺癌
    • 黒色腫
    • その他(大腸癌)
  • エンドユーザー別
    • 診療所・病院
    • 研究センター

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Agilent Technologies, Inc.
  • Almac Group Ltd.
  • Biodesix, Inc.
  • Biospherex LLC
  • Cepheid
  • Cernostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • General Electric Co.
  • Genomic Health, Inc.
  • Illumina, Inc.
  • Lunaphore Technologies S.A.
  • Metabiomics Corp.
  • Myriad Genetics, Inc.
  • Novartis International AG
  • OPKO Health, Inc.
  • PerkinElmer Inc.
  • Personalis, Inc.
  • QIAGEN N.V.
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
図表

LIST OF TABLES

  • GLOBAL CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • GLOBAL IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL IN SITU HYBRIDIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL SEQUENCING TECHNIQUES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL MASS SPECTROMETRY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • GLOBAL LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL MELANOMA CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • GLOBAL CLINICS AND HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • GLOBAL CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY,2018-2025 ($ MILLION)
  • NORTH AMERICAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • NORTH AMERICAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • NORTH AMERICAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • NORTH AMERICAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • EUROPEAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • EUROPEAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • EUROPEAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • EUROPEAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY , 2018-2025 ($ MILLION)
  • ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • REST OF THE WORLD CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • REST OF THE WORLD CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  • REST OF THE WORLD CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • GLOBAL CANCER/TUMOR PROFILING MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  • GLOBAL CANCER/TUMOR PROFILING MARKET SHARE BY CANCER TYPE, 2018 VS 2025 (%)
  • GLOBAL CANCER/TUMOR PROFILING MARKET SHARE BYEND-USER, 2018 VS 2025 (%)
  • GLOBAL CANCER/TUMOR PROFILING MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • US CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • CANADA CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • UK CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • FRANCE CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • GERMANY CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • ITALY CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • SPAIN CANCER/TUMOR PROFILINGPRODUCTS MARKET SIZE, 2018-2025 ($ MILLION)
  • ROE CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • INDIA CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • CHINA CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • JAPAN CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • REST OF ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  • REST OF THE WORLD CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019917

Title:
Global Cancer/Tumor Profiling
Market Size, Share & Trends Analysis Report by Technology (Immunoassays, In Situ Hybridization, Sequencing Techniques, Mass Spectrometry, and Others), by Cancer Type (Lung Cancer, Breast Cancer, Prostate Cancer, Melanoma Cancer, and Others), and by End-User (Clinics and Hospitals, and Research Centers) and Forecast 2019-2025.

The increasing demand for cancer/tumor profiling methods by the oncologists to diagnose and treat cancer is projected to drive global market. Additionally, the growing adoption of cancer biomarkers for tumor profiling along with the rising incidence of cancer across the globe is another factor to fuel the growth of the global market. Furthermore, the growing utility of the next-generation sequencing technique is anticipated to fuel the growth of the market. However, hefty investments for the development of biomarkers and lack of skilled professionals or oncologists specific to tumor profiling are likely to hamper market growth.

The cancer/tumor profiling market is segmented on the basis of technology, cancer type, and end-user. Based on technology, the market is segmented into immunoassays, in situ hybridization, sequencing techniques, mass spectrometry, and others. Among these technologies, the immunoassays are projected to hold a significant market share, owing to their high utilization as a gold standard for the conduction of large-scale tumor profiling.

Global cancer/tumor profiling market is further segmented on the basis of geography, including North America, Europe, Asia-Pacific, and Rest of the World. North America held a significant share in the global market in 2018. This is due to the well-developed healthcare infrastructure and rapid adoption of advanced technologies by the pharmaceutical companies. Asia-Pacific is anticipated to witness a considerable growth in the global cancer/tumor profiling market during the forecast period. This is owing to the increasing requirement of cancer/ tumor profiling kits due to the rising number of cancer cases in the region.

Key players of cancer/tumor profiling market include QIAGEN N.V., Genomic Health, Inc., Sysmex Corp., Illumina Inc., and Thermo Fisher Scientific Inc., and so on. In order to retain in the competitive market, these players adopt different growth strategies such as merger and acquisition, partnership, product launch, and collaboration to stay competitive in the market. For instance, in September 2017, INDIVUMED entered into a partnership with Helomics to unlock the power of cancer biospecimens for drug discovery and development.

Research Methodology

The market study of global cancer/tumor profiling market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for biotechnology companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • 1. Global Cancer/Tumor Profiling Market Research and Analysis by Technology
  • 2. Global Cancer/Tumor Profiling Market Research and Analysis by Cancer Type
  • 3. Global Cancer/Tumor Profiling Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive Research Methodologyof global cancer/tumor profiling market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting global cancer/tumor profiling market.
  • Insights about market determinants which are stimulating global cancer/tumor profiling market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. F. Hoffmann-La Roche Ltd.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Genomic Health, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Sysmex Corp.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. QIAGEN N.V.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Illumina, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cancer/Tumor Profiling Market by Technology
    • 5.1.1. Immunoassay
    • 5.1.2. In Situ Hybridization
    • 5.1.3. Sequencing techniques
    • 5.1.4. Mass spectrometry
    • 5.1.5. Others (Microarray)
  • 5.2. Global Cancer/Tumor Profiling Market by Cancer Type
    • 5.2.1. Lung cancer
    • 5.2.2. Breast cancer
    • 5.2.3. Prostate cancer
    • 5.2.4. Melanoma cancer
    • 5.2.5. Others (colorectal cancer)
  • 5.3. Global Cancer/Tumor Profiling Market by End-User
    • 5.3.1. Clinics and Hospitals
    • 5.3.2. Research Centers

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Agilent Technologies, Inc.
  • 7.2. Almac Group Ltd.
  • 7.3. Biodesix, Inc.
  • 7.4. Biospherex LLC
  • 7.5. Cepheid
  • 7.6. Cernostics, Inc.
  • 7.7. F. Hoffmann-La Roche Ltd.
  • 7.8. General Electric Co.
  • 7.9. Genomic Health, Inc.
  • 7.10. Illumina, Inc.
  • 7.11. Lunaphore Technologies S.A.
  • 7.12. Metabiomics Corp.
  • 7.13. Myriad Genetics, Inc.
  • 7.14. Novartis International AG
  • 7.15. OPKO Health, Inc.
  • 7.16. PerkinElmer Inc.
  • 7.17. Personalis, Inc.
  • 7.18. QIAGEN N.V.
  • 7.19. Sysmex Corp.
  • 7.20. Thermo Fisher Scientific Inc.